Biomarqueurs Idiopathic inflammatory myopathies Myopathy Dependovirus/genetics/immunology Immunotherapy Myositis and muscle disease Animals Analyses multidimensionnelles Anticorps anti-agalsidase Active Myositis Anti-synthetase syndrome Sphingosine-1-phosphate Anti‐mitochondrial antibodies CD8+ T-bet+ cells Biomarker Data integration Acute Kidney Injury/epidemiology/etiology Case reports Skeletal muscle AAV vector Immune checkpoint inhibitors B-lymphocyte Adolescence COVID-19 Adjudication Antibody responses Auto‐antibodies Acid-alpha-glucosidase Muscle Interferon Antisynthétase Antisynthetase Anti-interleukin-6 Fabry disease Middle Aged Prognosis Aldosterone Amyotrophy CD8+T cells DM Outcome measures Anti-MDA5 autoantibodies Autoimmunity Interstitial lung disease Bioelectrical impedance analysis Lysosomal storage diseases Biomarkers Inclusion body myositis Inflammation AAV vectors AAV Autoantibodies Anti-agalsidase antibodies Myocarditis Male Aged Antiphospholipid syndrome Cancer Adverse drug reactions IMNM Adeno-associated virus vector Inflammatory myopathy Mass cytometry Cytokines Adeno-associated vector Biopsy Abnormal movement Machine learning Amyotrophic lateral sclerosis AAV humoral immunity Gene therapy Anémie hémolytique Anti-Mi2 Adeno-associated virus Systems biology Adult Arthritis Anti-drug antibodies Humans Dermatomyositis Multidisciplinarity Assisted communication devices Antibodies Polymyositis IBM Female Autoimmune diseases Anti-IgE IgG Agalsidase B cell homeostasis Antisynthetase syndrome Auto-immunité Deep immune profiling Anticorps spécifique des myosites Auto-antibodies Inborn errors of metabolism Aldostérone AAV antibody Autoantibody